Ergoteles’s Annexon ANNX Stock Holding History

Ergoteles’s Portfolio ANNX Stock Details ANNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-51,300	Closed	-$181K	–	82
2023 Q2	$181K	Buy	+51,300	New	+$224K	0.01%	863
2022 Q3	–	Sell	-130,200	Closed	-$491K	–	1529
2022 Q2	$491K	Buy	+130,200	New	+$398K	0.01%	846

Other funds holding ANNX

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Ergoteles's ANNX Position: Q3 2023 in Review

Ergoteles sold out of Annexon (ANNX) in Q3 2023, closing a stake of 51,300 shares — an estimated $181K sold.

Ergoteles first reported a position in ANNX in Q2 2022 and held it in 2 quarters. The position peaked at $491K in Q2 2022. 93 funds tracked by Wall St. Rank hold ANNX as of Q3 2023.

Ergoteles reported no remaining Annexon position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 51,300 Annexon shares in Q3 2023, an estimated $181K.
Ergoteles first reported a position in Annexon in Q2 2022 and held it in 2 quarters.
Ergoteles's Annexon position peaked at $491K in Q2 2022.
93 funds tracked by Wall St. Rank held Annexon as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.